Wall Street Analysts Believe Rigel (RIGL) Could Rally 44.93%: Here's is How to Trade
Portfolio Pulse from
Wall Street analysts have set a mean price target for Rigel Pharmaceuticals (RIGL) that suggests a potential 44.9% upside. Despite the mixed reliability of price targets, the consensus on increased earnings estimates supports a positive outlook for the stock.
March 05, 2025 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have set a mean price target for Rigel Pharmaceuticals (RIGL) indicating a potential 44.9% upside. The consensus on raising earnings estimates supports this positive outlook.
The article highlights a significant potential upside for RIGL based on analyst price targets and consensus on increased earnings estimates. This suggests a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100